Emergent BioSolutions Inc.
EBS
$8.71
-$0.49-5.33%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 79.28% | 49.85% | -33.62% | 115.06% | -11.21% |
| Total Receivables | -60.82% | 31.84% | 27.37% | -38.21% | -15.93% |
| Inventory | 7.83% | 0.74% | -3.41% | 1.64% | -4.77% |
| Prepaid Expenses | -20.53% | 12.27% | -55.90% | 69.44% | -1.37% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 60.66% | -6.15% | -81.43% | 6,900.00% |
| Total Current Assets | 1.80% | 18.06% | -9.48% | 1.05% | -4.09% |
|
|
|||||
| Total Current Assets | 1.80% | 18.06% | -9.48% | 1.05% | -4.09% |
| Net Property, Plant & Equipment | -1.67% | -19.38% | -2.82% | -9.19% | -18.95% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -3.34% | -3.25% | -3.15% | -3.05% | -2.96% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -26.15% | -9.72% | -11.11% | 62.00% | -97.16% |
| Total Assets | -0.63% | 2.62% | -5.96% | -2.36% | -16.08% |
|
|
|||||
| Total Accounts Payable | 9.64% | -4.60% | -25.82% | -14.39% | -4.29% |
| Total Accrued Expenses | 19.00% | -48.64% | -7.05% | -5.36% | 49.02% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.26% | -29.63% | -22.86% | -99.16% | -9.56% |
| Total Finance Division Other Current Liabilities | 17.86% | -44.00% | -61.48% | 200.46% | 92.86% |
| Total Other Current Liabilities | 17.86% | -44.00% | -61.48% | 200.46% | 92.86% |
| Total Current Liabilities | 13.58% | -31.10% | -29.36% | -62.90% | -1.67% |
|
|
|||||
| Total Current Liabilities | 13.58% | -31.10% | -29.36% | -62.90% | -1.67% |
| Long-Term Debt | 0.32% | 0.30% | 0.29% | 48.05% | 0.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 27.45% | -47.42% | -9.35% | -6.96% | -11.54% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -12.35% | 27.57% | 6.12% | 36.73% | -1.61% |
| Total Liabilities | 0.86% | -3.69% | -6.45% | -14.00% | -1.10% |
|
|
|||||
| Common Stock & APIC | 0.47% | 0.30% | 0.39% | 0.99% | 0.60% |
| Retained Earnings | -8.31% | 32.02% | -17.28% | 38.80% | -2,211.72% |
| Treasury Stock & Other | -3.81% | -0.39% | 0.89% | -0.77% | 0.00% |
| Total Common Equity | -2.99% | 14.48% | -5.04% | 31.61% | -41.81% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.99% | 14.48% | -5.04% | 31.61% | -41.81% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.99% | 14.48% | -5.04% | 31.61% | -41.81% |
|
|
|||||